Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population (2018)

  • Authors:
  • USP affiliated authors: ZERBINI, MARIA CLAUDIA NOGUEIRA - FM
  • USP Schools: FM
  • DOI: 10.1038/s41598-018-20133-6
  • Subjects: LINFOMA; PREVALÊNCIA; BRASILEIROS
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1038/s41598-018-20133-6 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAMPOS, Antonio Hugo Jose Froes Marques; ZERBINI, Maria Claudia. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population. Scientific reports, London, v. 8, 2018. Disponível em: < http://dx.doi.org/10.1038/s41598-018-20133-6 > DOI: 10.1038/s41598-018-20133-6.
    • APA

      Campos, A. H. J. F. M., & Zerbini, M. C. (2018). Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population. Scientific reports, 8. doi:10.1038/s41598-018-20133-6
    • NLM

      Campos AHJFM, Zerbini MC. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population [Internet]. Scientific reports. 2018 ; 8Available from: http://dx.doi.org/10.1038/s41598-018-20133-6
    • Vancouver

      Campos AHJFM, Zerbini MC. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population [Internet]. Scientific reports. 2018 ; 8Available from: http://dx.doi.org/10.1038/s41598-018-20133-6

    Referências citadas na obra
    Grywalska, E. & Rolinski, J. Epstein-Barr virus-associated lymphomas. Semin Oncol 42, 291–303 (2015).
    Correa, P. & O’Conor, G. T. Epidemiologic patterns of Hodgkin’s disease. Int J Cancer 8, 192–201 (1971).
    Glaser, S. L. & Jarrett, R. F. The epidemiology of Hodgkin’s disease. Bailliere Clin Haematol 9, 401–16 (1996).
    Koh, Y. W. et al. Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea. Ann Hematol 92, 1653–60 (2013).
    Zarate-Osorno, A., Roman, L. N., Kingma, D. W., Meneses-Garcia, A. & Jaffe, E. S. Hodgkin’s disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 75, 1360–6 (1995).
    Chang, K. L., Albújar, P. F. & Chen, Y. Y. et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin’s disease occurring in Peru. Blood 81, 496 (1993).
    Leoncini, L. et al. Neoplastic cells of Hodgkin’s disease show differences in EBV expression between Kenya and Italy. Int J Cancer 65, 781–4 (1996).
    Makar, R. R., Saji, T. & Junaid, T. A. Epstein-Barr virus expression in Hodgkin’s lymphoma in Kuwait. Pathol Oncol Res 9, 159–65 (2003).
    Al-Salam, S., John, A., Daoud, S., Chong, S. M. & Castella, A. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals. Leuk Lymphoma 49, 1769–77 (2008).
    Hjalgrim, H., Seow, A., Rostgaard, K. & Friborg, J. Changing patterns of Hodgkin lymphoma incidence in Singapore. Int J Cancer 123, 716–9 (2008).
    Huang, X. et al. Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China. PLoS One 6, e21152 (2011).
    Sughayer, M. A., Haddad, H. A., Al-Yousef, R. M., El-Khateeb, M. & Abu-Rass, H. Epstein-Barr virus and Hodgkin lymphoma in Jordan. Hematol Oncol Stem Cell Ther 7, 85–9 (2014).
    de Souza, C. A., Vassallo, J. & Lorand-Metze, I. Hodgkin’s disease in Brazil: a clinicopathologic study. Haematologica 82, 127–8 (1997).
    Vassallo, J., Metze, K., Traina, F., de Souza, C. A. & Lorand-Metze, I. Expression of Epstein-Barr virus in classical Hodgkin’s lymphomas in Brazilian adult patients. Haematologica 86, 1227–8 (2001).
    Elgui de Oliveira, D., Bacchi, M. M., Abreu, E. S., Niero-Melo, L. & Bacchi, C. E. Hodgkin disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein-Barr virus infection. Am J Clin Pathol 118, 25–30 (2002).
    Vassallo, J. et al. Histological classification of 1,025 cases of Hodgkin’s lymphoma from the State of São Paulo, Brazil. Sao Paulo Med J. 123, 134–6 (2005).
    Araujo, I. et al. The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil. Virchows Arch 449, 315–9 (2006).
    Chabay, P. A. et al. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol 30, 285–91 (2008).
    Barros, M. H., Hassan, R. & Niedobitek, G. Disease patterns in pediatric classical Hodgkin lymphoma: a report from a developing area in Brazil. Hematol Oncol 29, 190–5 (2011).
    Kapatai, G. & Murray, P. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 60, 1342–9 (2007).
    Chang, E. T. et al. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis 189, 2271–81 (2004).
    Whitacre, C. C., Reingold, S. C. & O’Looney, P. A. A gender gap in autoimmunity. Science 283, 1277–8 (1999).
    Lee, M. Y., Tan, T. D. & Feng, A. C. Clinico-pathological study of Hodgkin’s lymphoma in a cancer center in Taiwan. Clin Lab Haematol 27, 379–383 (2005).
    Instituto Nacional do Câncer. Available from, http://www.inca.gov.br/estimativa/2016/. Acessed 7 November 2017.
    Kusminsky, G., Abriata, G., Forman, D. & Sierra, M. S. Hodgkin lymphoma burden in Central and South America. Cancer Epidemiol 2016 44(Suppl 1), S158–S167 (2016).
    International Agency for Research on Cancer. Cancer Incidence in Five Continents [Internet]. Availavle from, http://ci5.iarc.fr. Accessed 27 December 2017.
    Ferlay J et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; Available from: http://globocan.iarc.fr. Accessed 27 December 2017 (2013)
    Swerdlow, S. H. et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed (eds Bosman, F. T., Jaffe, E. S., Lakhani, S. R. & Ohgaki, H.) 321–334 (Lyon, France: International Agency for Research on Cancer, 2008).
    Fundação Oncocentro de São Paulo. Available from www.fosp.saude.sp.gov.br/publicacoes/rhc. Accessed 21 July 2017.
    Hasenclever, D. & Diehl, V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 339, 1506–4 (1998).
    Instituto Brasileiro de Geografia e Estatística (IBGE). Indicadores Sociodemográficos e de Saúde no Brasil. Available from, https://www.ibge.gov.br/estatisticas-novoportal/sociais/saude/9336-indicadores-sociodemograficos-e-de-saude-no-brasil.html. Acessed 7 November 2017.
    Campos, A. H., Vassallo, J. & Soares, F. A. Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma. PLoS One 8, e74793 (2013).
    Campos, A. H., Aldred, V. L., Ribeiro, K. C., Vassallo, J. & Soares, F. A. Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma. Mol Cell Biochem 321, 95–102 (2009).
    Gulley, M. L. et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin Lymphoma. Am J Clin Pathol 117, 259–67 (2002).
    Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159–74 (1977).